| Primary |
| Attention Deficit/hyperactivity Disorder |
44.6% |
| Product Used For Unknown Indication |
24.3% |
| Add |
5.4% |
| Depression |
5.4% |
| Narcolepsy |
5.4% |
| Drug Use For Unknown Indication |
2.7% |
| Major Depression |
2.7% |
| Adhd |
1.4% |
| Adhd, Predominantly Inattentive Type |
1.4% |
| Drug Dispensing Error |
1.4% |
| Fatigue |
1.4% |
| Generalised Anxiety Disorder |
1.4% |
| Hypersomnia |
1.4% |
| Sleep Disorder |
1.4% |
|
| Product Substitution Issue |
24.0% |
| Drug Ineffective |
18.0% |
| Therapeutic Response Unexpected With Drug Substitution |
10.0% |
| Completed Suicide |
4.0% |
| Hyperhidrosis |
4.0% |
| Rash |
4.0% |
| Somnolence |
4.0% |
| Therapeutic Response Decreased |
4.0% |
| Vision Blurred |
4.0% |
| Vomiting |
4.0% |
| Adrenal Insufficiency |
2.0% |
| Aggression |
2.0% |
| Crying |
2.0% |
| Death |
2.0% |
| Depression |
2.0% |
| Drug Effect Decreased |
2.0% |
| Drug Eruption |
2.0% |
| Dysgeusia |
2.0% |
| Feeling Abnormal |
2.0% |
| Hernia |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
22.0% |
| Attention Deficit/hyperactivity Disorder |
20.0% |
| Narcolepsy |
18.5% |
| Drug Use For Unknown Indication |
6.0% |
| Insomnia |
4.5% |
| Abnormal Behaviour |
4.0% |
| Anxiety |
3.5% |
| Systemic Lupus Erythematosus |
3.0% |
| Psychotic Disorder |
2.5% |
| Depression |
2.0% |
| Disturbance In Attention |
2.0% |
| Head Injury |
2.0% |
| Jaw Disorder |
1.5% |
| Ovarian Cyst Ruptured |
1.5% |
| Pain |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Bipolar Ii Disorder |
1.0% |
| Dementia Alzheimer's Type |
1.0% |
| Depressive Symptom |
1.0% |
| Hypertension |
1.0% |
|
| Paranoia |
7.9% |
| Therapeutic Response Decreased |
7.9% |
| Toxicity To Various Agents |
7.9% |
| Aggression |
5.3% |
| Aortic Valve Incompetence |
5.3% |
| Coeliac Disease |
5.3% |
| Completed Suicide |
5.3% |
| Cushing's Syndrome |
5.3% |
| Intraocular Pressure Increased |
5.3% |
| Irritability |
5.3% |
| Malaise |
5.3% |
| Somnolence |
5.3% |
| Tachyphrenia |
5.3% |
| Ventricular Hypoplasia |
5.3% |
| Weight Increased |
5.3% |
| Affect Lability |
2.6% |
| Attention Deficit/hyperactivity Disorder |
2.6% |
| Cardiac Arrest |
2.6% |
| Cardiomyopathy |
2.6% |
| Choreoathetosis |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Drug Use For Unknown Indication |
11.9% |
| Pain |
10.6% |
| Depression |
8.7% |
| Attention Deficit/hyperactivity Disorder |
7.8% |
| Bipolar Disorder |
5.4% |
| Cataplexy |
5.4% |
| Narcolepsy |
4.8% |
| Anxiety |
3.3% |
| Asthma |
2.7% |
| Smoking Cessation Therapy |
2.4% |
| Hypertension |
2.2% |
| Muscle Spasms |
2.2% |
| Diabetes Mellitus |
1.9% |
| Acne |
1.6% |
| Insomnia |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Medical Diet |
1.4% |
| Migraine |
1.4% |
| Neuropathy Peripheral |
1.4% |
|
| Weight Increased |
15.8% |
| Weight Decreased |
10.9% |
| Nausea |
8.9% |
| Vomiting |
6.9% |
| Pain |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Somnolence |
5.0% |
| Pneumonia |
4.0% |
| Pulmonary Embolism |
4.0% |
| Swelling |
4.0% |
| Abortion Spontaneous |
3.0% |
| Depression |
3.0% |
| Drug Ineffective |
3.0% |
| Fatigue |
3.0% |
| Granulocytopenia |
3.0% |
| Poor Quality Sleep |
3.0% |
| Product Quality Issue |
3.0% |
| Pruritus |
3.0% |
| Suicidal Ideation |
3.0% |
| Abdominal Pain |
2.0% |
|
